Clorox (NYSE:CLX) Given New $135.00 Price Target at Wells Fargo & Company

Clorox (NYSE:CLX) had its target price lowered by stock analysts at Wells Fargo & Company from $140.00 to $135.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “underweight” rating on the stock. Wells Fargo & Company‘s target price points to a potential downside of 2.34% from the company’s current price.

CLX has been the subject of a number of other research reports. UBS Group decreased their price target on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a report on Wednesday. Barclays decreased their price target on shares of Clorox from $136.00 to $132.00 and set an “underweight” rating for the company in a report on Thursday. Evercore ISI decreased their price target on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a report on Wednesday. Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target for the company in a report on Tuesday, March 26th. Finally, DA Davidson reaffirmed a “neutral” rating and issued a $162.00 price target on shares of Clorox in a report on Wednesday, April 17th. Four analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $146.43.

Clorox Trading Down 1.0 %

NYSE:CLX opened at $138.23 on Thursday. Clorox has a 52 week low of $114.68 and a 52 week high of $176.24. The firm has a 50 day moving average of $148.74 and a 200 day moving average of $143.08. The company has a quick ratio of 0.57, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The stock has a market capitalization of $17.17 billion, a price-to-earnings ratio of 71.62, a PEG ratio of 2.08 and a beta of 0.44.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. The business had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The business’s quarterly revenue was down 5.3% on a year-over-year basis. During the same quarter last year, the company posted $1.51 earnings per share. As a group, sell-side analysts anticipate that Clorox will post 5.85 earnings per share for the current fiscal year.

Institutional Trading of Clorox

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Choreo LLC grew its position in Clorox by 12.8% during the fourth quarter. Choreo LLC now owns 5,741 shares of the company’s stock valued at $819,000 after buying an additional 652 shares during the period. abrdn plc grew its position in Clorox by 20.1% during the fourth quarter. abrdn plc now owns 198,250 shares of the company’s stock valued at $28,268,000 after buying an additional 33,135 shares during the period. International Assets Investment Management LLC grew its position in shares of Clorox by 17,658.5% in the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after purchasing an additional 481,725 shares during the period. Adage Capital Partners GP L.L.C. acquired a new stake in shares of Clorox in the third quarter valued at about $6,605,000. Finally, Eagle Rock Investment Company LLC acquired a new stake in shares of Clorox in the fourth quarter valued at about $2,940,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.